drug development

Bristol Myers expands footprint in India with drug development and IT center
Endpoints
Thu, 02/23/23 - 04:28 pm
Bristol Myers Squibb
India
drug development
IT
After pandemic breather, Big Pharma sees drug development costs rise and returns sink: report
Fierce Biotech
Wed, 02/8/23 - 11:08 pm
drug development
Big Pharma
Federal panel approves plans to safeguard lab-made virus research
Stat
Sun, 01/29/23 - 01:27 pm
viruses
R&D
gain of function
drug development
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio
BioSpace
Sun, 01/22/23 - 01:09 pm
Regen Biopharma
exosomes
cancer
drug development
BMJ finds 96% of oncology drug developers inadequately include minority groups
Clinical Trials Arena
Fri, 01/13/23 - 11:06 am
BMJ
FDA
oncology
minorities
drug development
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
Businesswire
Mon, 01/9/23 - 10:37 am
Eli Lilly
TRexBio
tregs
drug development
Delpharm acquires injectable drug development center in the Netherlands from Dr Reddy's
Biopharma Reporter
Thu, 01/5/23 - 10:11 am
Delpharm
CDMOs
drug development
The Netherlands
Dr Reddy's
Lilly Plunks Down up to $731M in GPCR Pact with Sosei
BioSpace
Fri, 12/16/22 - 10:27 am
Eli Lilly
Sosei
drug discovery
drug development
diabetes
metabolic disorders
Alzheimer’s disease drug development: three major questions for 2023
Clinical Trials Arena
Wed, 12/7/22 - 11:34 pm
Alzheimer's disease
drug development
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
BioSpace
Tue, 12/6/22 - 10:42 am
AbbVie
HotSpot Therapeutics
drug discovery
drug development
autoimmune disease
AstraZeneca, C4XD sign exclusive $402 million global license
Pharmaphorum
Mon, 11/28/22 - 10:20 am
AstraZeneca
C4XD
drug development
COPD
Merck KGaA outlines plan to rev up drug R&D
BioPharma Dive
Mon, 11/21/22 - 06:36 pm
Merck KGaA
drug development
R&D
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Motley Fool
Mon, 11/21/22 - 09:55 am
Bristol Myers Squibb
drug development
Inflation Reduction Act
mRNA drugs with a built-in ‘copy machine’ could lead to safer, more effective therapies
Stat
Fri, 11/18/22 - 10:28 am
MRNA
drug development
Regeneron, CytomX Ink Potentially $2B Bispecific Immunotherapy Deal
BioSpace
Thu, 11/17/22 - 12:05 pm
Regeneron
CytomX Therapeutics
bispecifics
cancer
Veloci-Bi
drug development
Roche Doubles Down on Jnana's RAPID Platform in $2B Deal (Updated)
BioSpace
Wed, 11/16/22 - 10:13 am
Roche
Jnana Therapeutics
small molecule drugs
drug development
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
MRNA
drug development
Moderna Therapeutics
Ultragenyx
Omega Therapeutics
BioNTech
cancer
OTX-2002
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Kyowa Kirin
Takeda
Eiger BioPharmaceuticals
AstraZeneca
Teva Pharmaceutical
Bavarian Nordic
Halozyme
Novartis
MannKind
drug development
GSK decides time is right to pay Tempus $70M to expand access to patient data library
Fierce Biotech
Tue, 10/18/22 - 10:58 am
GSK
Tempus
drug development
clinical trials
artificial intelligence
Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal
BioSpace
Mon, 10/17/22 - 10:26 am
Gilead Sciences
Macrogenics
hematological cancers
drug development

Pages